Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
BioMarin Pharmaceutical Inc banner

BioMarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
BioMarin Pharmaceutical Inc Logo
BioMarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 62.225 USD -1.81%
Market Cap: $12B
Write Note Create Alert Ask AI

Wall St Price Targets

BMRN Price Forecast
Based on 28 analysts

+48% Upside
from $62.225 today

BMRN Analyst Rating
Based on 29 analysts

Strong buy
16 55%
Buy
7 24%
Hold
6 21%
Sell
0 0%
Strong sell
0 0%
BioMarin Pharmaceutical Inc Competitors:
Price Targets

Revenue
Forecast

15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.

What are analyst estimates?

Gross Profit
Forecast

15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat
N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
20%
Average Beat

The compound annual growth rate for Operating Income over the next 8 years is 14%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

The compound annual growth rate for Net Income over the next 8 years is 24%.

What are analyst estimates?

Continue BMRN Research

Summary
BMRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BMRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BMRN stock valuation using valuation multiples.
Wall St Estimates
BMRN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BMRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other BioMarin Pharmaceutical Inc listings:
F • EUR
BM8
 XMUN • EUR
BM8
 SWB • EUR
BM8
 LSE • USD
0HNC
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BMRN's stock price target?
Price Target
91.8 USD

According to Wall Street analysts, the average 1-year price target for BMRN is 91.8 USD with a low forecast of 60.6 USD and a high forecast of 130.2 USD.

What is the Revenue forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.

What is the Gross Profit forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.

What is the Operating Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
14%

The compound annual growth rate for Operating Income over the next 8 years is 14%.

What is the Pre-Tax Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
48%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.

What is the Net Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
24%

The compound annual growth rate for Net Income over the next 8 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.